The present invention is directed to DNA sequence encoding
angiogenesis-inhibiting recombinant chimeric protein, the chimeric
protein per se, the pharmaceutical use of the chimeric protein, and to
the pharmaceutical composition containing the recombinant protein and the
formulation thereof.